Subtopic Deep Dive

Exome Sequencing in Mendelian Disorders
Research Guide

What is Exome Sequencing in Mendelian Disorders?

Exome sequencing in Mendelian disorders applies targeted next-generation sequencing of protein-coding regions to identify causal rare variants in monogenic diseases.

Whole-exome sequencing (WES) enables diagnosis of undiagnosed cases through trio analysis and phenotype-driven variant filtering. Bamshad et al. (2011) reviewed WES as a tool for Mendelian gene discovery (1672 citations). Ng et al. (2009) first demonstrated WES identifying a causal variant in a Miller syndrome family (1926 citations). Over 50 key papers exist on WES diagnostics and standards.

Curated Papers

Key Challenges

Why It Matters

Exome sequencing diagnoses ~30% of unsolved Mendelian cases, enabling gene discovery for conditions like intellectual disability (de Ligt et al., 2012, 1558 citations). ACMG guidelines by Richards et al. (2015, 30258 citations) standardize variant interpretation, guiding clinical decisions. Green et al. (2013, 2475 citations) provide protocols for incidental findings, impacting patient management in ~1 million annual exomes.

Key Research Challenges

Variant Pathogenicity Classification

Distinguishing pathogenic from benign variants requires integrating population frequency, functional predictions, and inheritance patterns. Richards et al. (2015) established ACMG/AMP guidelines for 28 criteria (30258 citations). Choi et al. (2012) developed PROVEAN for amino acid substitution effects (2936 citations).

Incidental and Secondary Findings

Reporting actionable incidental variants raises ethical issues in pediatric cases. Green et al. (2013) recommended 56 genes for incidental reporting (2475 citations). Kalia et al. (2016) updated to 59 genes with ACMG SF v2.0 (1658 citations).

De Novo Mutation Detection

Trio sequencing identifies de novo variants, but low mosaicism and sequencing depth challenge accuracy. de Ligt et al. (2012) diagnosed 16% of intellectual disability cases via de novo mutations (1558 citations). Karczewski et al. (2019) quantified mutational constraint across 141,456 humans (1767 citations).

Essential Papers

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · 2015 · Genetics in Medicine · 30.3K citations

Predicting the Functional Effect of Amino Acid Substitutions and Indels

Yongwook Choi, Gregory E. Sims, Sean V. Murphy et al. · 2012 · PLoS ONE · 2.9K citations

As next-generation sequencing projects generate massive genome-wide sequence variation data, bioinformatics tools are being developed to provide computational predictions on the functional effects ...

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Robert C. Green, Jonathan S. Berg, Wayne W. Grody et al. · 2013 · Genetics in Medicine · 2.5K citations

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Daniel Taliun, Daniel Harris, Michael D. Kessler et al. · 2021 · Nature · 2.1K citations

Abstract The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of impro...

Exome sequencing identifies the cause of a mendelian disorder

Sarah Ng, Kati J. Buckingham, Choli Lee et al. · 2009 · Nature Genetics · 1.9K citations

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

Marilyn M. Li, Michael Datto, Eric J. Duncavage et al. · 2016 · Journal of Molecular Diagnostics · 1.9K citations

The mutational constraint spectrum quantified from variation in 141,456 humans

Konrad J. Karczewski, Laurent C. Francioli, Grace Tiao et al. · 2019 · 1.8K citations

Summary Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes critical for an organism’s function wi...

Reading Guide

Foundational Papers

Start with Ng et al. (2009) for first WES success in Mendelian disease, Bamshad et al. (2011) for gene discovery review, and de Ligt et al. (2012) for de novo diagnostics.

Recent Advances

Study Richards et al. (2015) for variant guidelines, Karczewski et al. (2019) for constraint quantification, and Taliun et al. (2021) for population-scale exome reference.

Core Methods

ACMG/AMP classification (Richards et al., 2015), PROVEAN functional prediction (Choi et al., 2012), trio-based de novo calling, and phenotype-driven filtering (Bamshad et al., 2011).

How PapersFlow Helps You Research Exome Sequencing in Mendelian Disorders

Discover & Search

Research Agent uses searchPapers and exaSearch to find exome studies on Mendelian disorders, then citationGraph on Ng et al. (2009) reveals 1926-cited impacts and findSimilarPapers uncovers trio analyses like de Ligt et al. (2012).

Analyze & Verify

Analysis Agent applies readPaperContent to extract ACMG criteria from Richards et al. (2015), verifies variant predictions with runPythonAnalysis on PROVEAN scores (Choi et al., 2012), and uses verifyResponse (CoVe) with GRADE grading for evidence strength in diagnostic yields.

Synthesize & Write

Synthesis Agent detects gaps in de novo detection post-de Ligt et al. (2012), while Writing Agent uses latexEditText, latexSyncCitations for ACMG papers, and latexCompile to generate variant tables; exportMermaid diagrams inheritance models from trio data.

Use Cases

"Run statistical analysis on de novo mutation rates in exome trios for intellectual disability."

Research Agent → searchPapers(de Ligt 2012) → Analysis Agent → runPythonAnalysis(pandas on mutation frequencies, matplotlib plots) → researcher gets CSV of rates and p-values.

"Write LaTeX review of ACMG guidelines for exome variant interpretation."

Synthesis Agent → gap detection(Richards 2015) → Writing Agent → latexEditText(structure sections), latexSyncCitations(ACMG papers), latexCompile → researcher gets compiled PDF with figures.

"Find GitHub repos with exome analysis code for Mendelian filtering."

Research Agent → paperExtractUrls(Bamshad 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets repo summaries with variant filtering scripts.

Automated Workflows

Deep Research workflow scans 50+ exome papers via searchPapers, structures reports on diagnostic yields with GRADE grading. DeepScan applies 7-step CoVe to verify PROVEAN predictions (Choi et al., 2012) against TOPMed data (Taliun et al., 2021). Theorizer generates hypotheses on constraint spectra (Karczewski et al., 2019) for undiagnosed cases.

Try Doxa for Exome Sequencing in Mendelian Disorders Research

Frequently Asked Questions

What is exome sequencing in Mendelian disorders?

Exome sequencing targets ~1-2% of the genome encoding proteins to find rare causal variants in monogenic diseases like Miller syndrome (Ng et al., 2009).

What are key methods in exome analysis?

Trio sequencing detects de novo mutations; phenotype-driven filtering and ACMG criteria classify variants (Richards et al., 2015; Bamshad et al., 2011).

What are major papers?

Foundational: Ng et al. (2009, 1926 citations), Bamshad et al. (2011, 1672 citations); standards: Richards et al. (2015, 30258 citations).

What open problems remain?

Improving low-frequency variant detection, standardizing secondary findings (Kalia et al., 2016), and integrating constraint metrics (Karczewski et al., 2019).